AIFarm, Ltd.
AIFM · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -0.01 | 0.09 | -0.03 |
| FCF Yield | -25.24% | -18.62% | -10.09% | -7.22% |
| EV / EBITDA | -10.74 | -3.08 | -15.59 | -12.58 |
| Quality | ||||
| ROIC | 1.66% | 6.50% | 2.22% | 3.92% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.47 | 0.72 | 1.70 | 0.98 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -9.00% | -20.98% | 2.57% | 90.18% |
| Safety | ||||
| Net Debt / EBITDA | 0.56 | 0.77 | 1.23 | 1.08 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |